June 16 (Reuters) - Medexus Pharmaceuticals Inc MDP.V :
* MEDEXUS REVENUE INCREASES 43.5% TO A RECORD US$79.7
MILLION FOR
FISCAL 2021
* MEDEXUS PHARMACEUTICALS INC - CASH AND CASH EQUIVALENTS OF
$18.7
MILLION AND AVAILABLE LIQUIDITY OF $24.8 MILLION AT MARCH 31,
2021
* MEDEXUS PHARMACEUTICALS INC - REVENUE OF $17.6 MILLION IN
Q4,
COMPARED TO $18.8 MILLION FOR SAME PERIOD LAST YEAR
* MEDEXUS PHARMACEUTICALS INC - QTRLY NET LOSS OF $10.5
MILLION
COMPARED TO $1.6 MILLION FOR SAME PERIOD LAST YEAR
* MEDEXUS PHARMACEUTICALS INC - QTRLY ADJUSTED NET LOSS OF
$5.2
MILLION COMPARED TO $5.1 MILLION FOR SAME PERIOD LAST YEAR
Source text for Eikon: ID:nGNX5Dw5Wt
Further company coverage: MDP.V
((Reuters.Briefs@thomsonreuters.com;))